Back
Harmony Biosciences Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
80
HRMY
Harmony Biosciences Holdings
Last Price:
38.96
Seasonality Move:
3.26%
Sell
27
ALNY
Alnylam Pharmaceuticals
Last Price:
276.54
Seasonality Move:
5.61%
Buy
80
Harmony Biosciences Holdings (HRMY)
is a Buy
Is Harmony Biosciences Holdings a Buy, Sell or Hold?
- The current Harmony Biosciences Holdings [HRMY] share price is $38.34. The Score for HRMY is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- HRMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $273.15. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRMY Stock Price Chart
What is Harmony Biosciences Holdings's stock price today?
-
The Harmony Biosciences Holdings share price today is $38.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRMY is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $273.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
HRMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.09 | Buy |
| Relative Strength Index (14 RSI): | 64.21 | Buy |
| Chaikin Money Flow: | -337293 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.31 - 37.73) | Buy |
| Bollinger Bands (100): | (29.77 - 35.39) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.49 | Buy |
| Relative Strength Index (14 RSI): | 58.43 | Buy |
| Chaikin Money Flow: | -281455 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (256.46 - 277.82) | Buy |
| Bollinger Bands (100): | (163.13 - 268.55) | Buy |
HRMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.04 | Buy |
| 20-day SMA: | 36.8 | Buy |
| 50-day SMA: | 34.95 | Buy |
| 200-day SMA: | 32.18 | Buy |
| 8-day EMA: | 37.99 | Buy |
| 20-day EMA: | 36.91 | Buy |
| 50-day EMA: | 35.16 | Buy |
| 200-day EMA: | 33.02 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 264.5 | Buy |
| 20-day SMA: | 266.49 | Buy |
| 50-day SMA: | 259.42 | Buy |
| 200-day SMA: | 191.14 | Buy |
| 8-day EMA: | 267.08 | Buy |
| 20-day EMA: | 264.76 | Buy |
| 50-day EMA: | 252.59 | Buy |
| 200-day EMA: | 207.34 | Buy |
Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.24 per share, a decrease this year of $0.14 per share, and an increase next year of $2.29 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Harmony Biosciences Holdings Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||